Individuals with blood type O may have lowest risk of COVID-19, find studies
Two retrospective studies in Blood Advances have added to the growing evidence supporting an association between blood type and COVID-19 vulnerability, indicating that people with blood type O may be less susceptible to infection and experience milder disease.
A Danish study compared data from around 473,000 COVID-19–positive individuals with a control group of 2.2 million people in the general population,
The results indicated fewer infected people with blood type O (risk ratio [RR], 0.87, 95% confidence interval [CI], 0.82 to 0.91, P < 0.001) and more people with A, B, and AB types. No associations were found between non-O blood groups and comorbidities that might explain infection rate differences.
The authors hypothesized that the presence of virus-neutralizing anti-A and anti-B antibodies on mucosal surfaces of some type O individuals may explain the relative protection for this blood type.
A second study of 95 critically ill COVID-19 patients in a Vancouver, Canada, hospital found that—after adjusting for sex, age, and comorbidities—patients with blood types A or AB were more likely to require mechanical ventilation than patients with types O or B (84% vs 61%, P = 0.02), indicating higher rates of lung damage.
Patients with blood types A and AB also had higher rates of dialysis for kidney failure, suggesting increased organ dysfunction or failure due to COVID-19 (32% vs 95%, P = 0.004). Patients with blood types A and AB did not have longer hospital stays than those with types O or B, but they did experience longer intensive care unit stays, which may signal greater COVID-19 severity.
"The unique part of our study is our focus on the severity effect of blood type on COVID-19. We observed this lung and kidney damage, and in future studies, we will want to tease out the effect of blood group and COVID-19 on other vital organs," said study author Mypinder S. Sekhon, MD, of the University of British Columbia in a news release yesterday.
"Of particular importance as we continue to traverse the pandemic, we now have a wide range of survivors who are exiting the acute part of COVID-19, but we need to explore mechanisms by which to risk stratify those with longer-term effects," he added.
Though these new studies add evidence that there may be an association between blood type and vulnerability to COVID-19; however, additional research is needed to better understand why and what it means for patients.
For the full article,follow the link: https://doi.org/10.1182/bloodadvances.2020002657
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.